O	O	O	0	14	Anaphylatoxins	Anaphylatoxin	B-NP	NNS	B-protein	4	NMOD	B-protein
T1	B-Protein	B-Protein	15	18	C5a	C5a	I-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	19	22	and	and	I-NP	CC	O	4	NMOD	O
T2	B-Protein	B-Protein	23	26	C3a	C3a	I-NP	NN	B-protein	5	SUB	B-protein
O	O	O	27	33	induce	induce	B-VP	VBP	O	0	ROOT	O
T19	B-Entity	B-Entity	34	41	nuclear	nuclear	B-NP	JJ	B-protein	8	NMOD	B-protein
T19	I-Entity	I-Entity	42	48	factor	factor	I-NP	NN	I-protein	8	NMOD	I-protein
T19	I-Entity	I-Entity	49	55	kappaB	kappaB	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	56	66	activation	activation	I-NP	NN	O	5	OBJ	O
O	O	O	67	69	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	70	75	human	human	B-NP	JJ	B-cell_type	14	NMOD	B-cell_type
O	O	O	76	86	peripheral	peripheral	I-NP	JJ	I-cell_type	14	NMOD	I-cell_type
O	O	O	87	92	blood	blood	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	O	93	102	monocytes	monocyte	I-NP	NNS	I-cell_type	10	PMOD	I-cell_type
O	O	O	102	103	.	.	O	.	O	5	P	O

O	O	O	105	108	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	109	123	anaphylatoxins	anaphylatoxin	I-NP	NNS	B-protein	5	NMOD	B-protein
T3	B-Protein	B-Protein	124	127	C5a	C5a	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	128	131	and	and	I-NP	CC	O	5	NMOD	O
T4	B-Protein	B-Protein	132	135	C3a	C3a	I-NP	NN	B-protein	6	SUB	B-protein
O	O	O	136	139	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	140	148	involved	involve	I-VP	VBN	O	6	VC	O
O	O	O	149	151	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	152	155	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	156	166	regulation	regulation	I-NP	NN	O	8	PMOD	O
O	O	O	167	169	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	170	178	cytokine	cytokine	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	179	189	production	production	I-NP	NN	O	11	PMOD	O
O	O	O	189	190	.	.	O	.	O	6	P	O

O	O	O	191	193	In	In	B-PP	IN	O	15	VMOD	O
O	O	O	194	198	this	this	B-NP	DT	O	3	NMOD	O
O	O	O	199	204	study	study	I-NP	NN	O	1	PMOD	O
O	O	O	205	208	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	209	219	capability	capability	I-NP	NN	O	15	SUB	O
O	O	O	220	222	of	of	B-PP	IN	O	5	NMOD	O
T5	B-Protein	B-Protein	223	226	C5a	C5a	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	227	230	and	and	I-NP	CC	O	9	NMOD	O
T6	B-Protein	B-Protein	231	234	C3a	C3a	I-NP	NN	B-protein	6	PMOD	B-protein
O	O	O	235	237	to	to	B-VP	TO	O	11	VMOD	O
O	O	O	238	244	induce	induce	I-VP	VB	O	5	NMOD	O
T20	B-Entity	B-Entity	245	258	transcription	transcription	B-NP	NN	B-protein	14	NMOD	B-protein
T20	I-Entity	I-Entity	259	265	factor	factor	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	266	276	activation	activation	I-NP	NN	O	11	OBJ	O
O	O	O	277	280	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	281	289	examined	examine	I-VP	VBN	O	15	VC	O
O	O	O	289	290	.	.	O	.	O	15	P	O

T7	B-Protein	B-Protein	291	294	C5a	C5a	B-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	295	298	and	and	I-NP	CC	O	4	NMOD	O
T8	B-Protein	B-Protein	299	302	C3a	C3a	I-NP	NN	B-protein	4	NMOD	B-protein
O	O	O	303	314	stimulation	stimulation	I-NP	NN	O	10	SUB	O
O	O	O	315	317	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	318	323	human	human	B-NP	JJ	B-cell_type	9	NMOD	B-cell_type
O	O	O	324	334	peripheral	peripheral	I-NP	JJ	I-cell_type	9	NMOD	I-cell_type
O	O	O	335	340	blood	blood	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	O	341	350	monocytes	monocyte	I-NP	NNS	I-cell_type	5	PMOD	I-cell_type
O	O	O	351	359	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	360	362	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	363	370	nuclear	nuclear	B-NP	JJ	O	13	NMOD	O
O	O	O	371	381	expression	expression	I-NP	NN	O	11	PMOD	O
O	O	O	382	384	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	385	386	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	387	390	DNA	DNA	I-NP	NN	O	18	NMOD	O
O	O	O	391	398	binding	binding	I-NP	NN	O	18	NMOD	O
O	O	O	399	407	activity	activity	I-NP	NN	O	14	PMOD	O
O	O	O	408	412	with	with	B-PP	IN	O	13	NMOD	O
O	O	O	413	424	specificity	specificity	B-NP	NN	O	19	PMOD	O
O	O	O	425	427	to	to	B-PP	TO	O	20	NMOD	O
O	O	O	428	431	the	the	B-NP	DT	O	24	NMOD	O
T21	B-Entity	B-Entity	432	438	kappaB	kappaB	I-NP	NN	B-DNA	24	NMOD	B-DNA
T21	I-Entity	I-Entity	439	447	sequence	sequence	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	O	447	448	.	.	O	.	O	10	P	O

O	O	O	449	452	The	The	B-NP	DT	O	5	NMOD	O
T9	B-Protein	B-Protein	453	456	p50	p50	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	457	460	and	and	I-NP	CC	O	5	NMOD	O
T10	B-Protein	B-Protein	461	464	p65	p65	I-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	465	473	proteins	protein	I-NP	NNS	I-protein	15	SUB	I-protein
O	O	O	473	474	,	,	O	,	O	15	P	O
O	O	O	475	487	constituents	constituent	B-NP	NNS	O	15	SUB	O
O	O	O	488	490	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	491	494	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	495	505	prototypic	prototypic	I-NP	JJ	O	13	NMOD	O
T22	B-Entity	B-Entity	506	513	nuclear	nuclear	I-NP	JJ	B-protein	13	NMOD	B-protein
T22	I-Entity	I-Entity	514	520	factor	factor	I-NP	NN	I-protein	13	NMOD	I-protein
T22	I-Entity	I-Entity	521	527	kappaB	kappaB	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	527	528	,	,	O	,	O	7	P	O
O	O	O	529	533	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	534	544	identified	identify	I-VP	VBN	O	15	VC	O
O	O	O	545	547	as	as	B-PP	IN	O	16	VMOD	O
O	O	O	548	558	components	component	B-NP	NNS	O	17	PMOD	O
O	O	O	559	561	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	562	565	the	the	B-NP	DT	O	24	NMOD	O
T23	B-Entity	B-Entity	566	569	DNA	DNA	I-NP	NN	B-protein	24	NMOD	B-protein
T23	I-Entity	I-Entity	569	570	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
T23	I-Entity	I-Entity	570	577	protein	protein	I-NP	NN	I-protein	24	NMOD	I-protein
T23	I-Entity	I-Entity	578	587	complexes	complex	I-NP	NNS	I-protein	19	PMOD	I-protein
O	O	O	588	590	by	by	B-PP	IN	O	16	VMOD	O
O	O	O	591	595	anti	anti	B-NP	AFX	B-protein	29	NMOD	B-protein
O	O	O	595	596	-	-	I-NP	HYPH	I-protein	29	NMOD	I-protein
O	O	O	596	603	peptide	peptide	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	604	614	antibodies	antibody	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	O	615	617	in	in	B-PP	IN	O	16	VMOD	O
O	O	O	618	621	gel	gel	B-NP	NN	O	33	NMOD	O
O	O	O	622	632	supershift	supershift	I-NP	NN	O	33	NMOD	O
O	O	O	633	639	assays	assay	I-NP	NNS	O	30	PMOD	O
O	O	O	639	640	.	.	O	.	O	15	P	O

T11	B-Protein	B-Protein	641	644	C5a	C5a	B-NP	NN	B-protein	2	SUB	B-protein
O	O	O	645	652	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	653	659	kappaB	kappaB	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	O	660	667	binding	binding	I-NP	NN	O	5	NMOD	O
O	O	O	668	676	activity	activity	I-NP	NN	O	2	OBJ	O
O	O	O	677	680	was	be	B-VP	VBD	O	2	VMOD	O
O	O	O	681	689	detected	detect	I-VP	VBN	O	6	VC	O
O	O	O	690	692	15	15	B-NP	CD	O	9	NMOD	O
O	O	O	693	696	min	min	I-NP	NN	O	10	PMOD	O
O	O	O	697	702	after	after	B-PP	IN	O	7	VMOD	O
O	O	O	703	710	agonist	agonist	B-NP	NN	O	12	NMOD	O
O	O	O	711	722	stimulation	stimulation	I-NP	NN	O	10	PMOD	O
O	O	O	722	723	,	,	O	,	O	2	P	O
O	O	O	724	730	peaked	peak	B-VP	VBD	O	2	VMOD	O
O	O	O	731	733	at	at	B-PP	IN	O	14	VMOD	O
O	O	O	734	736	30	30	B-NP	CD	O	19	NMOD	O
O	O	O	736	737	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	O	737	739	40	40	I-NP	CD	O	19	NMOD	O
O	O	O	740	743	min	min	I-NP	NN	O	15	PMOD	O
O	O	O	743	744	,	,	O	,	O	2	P	O
O	O	O	745	748	and	and	O	CC	O	2	VMOD	O
O	O	O	749	757	remained	remain	B-VP	VBD	O	2	VMOD	O
O	O	O	758	768	detectable	detectable	B-ADJP	JJ	O	22	PRD	O
O	O	O	769	771	at	at	B-PP	IN	O	23	AMOD	O
O	O	O	772	773	2	2	B-NP	CD	O	26	NMOD	O
O	O	O	774	775	h	h	I-NP	NN	O	24	PMOD	O
O	O	O	775	776	.	.	O	.	O	2	P	O

O	O	O	777	784	Binding	Binding	B-NP	NN	O	5	SUB	O
O	O	O	785	787	to	to	B-PP	TO	O	1	NMOD	O
T24	B-Entity	B-Entity	788	794	kappaB	kappaB	B-NP	NN	B-DNA	4	NMOD	B-DNA
T24	I-Entity	I-Entity	795	803	sequence	sequence	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	O	804	807	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	808	819	accompanied	accompany	I-VP	VBN	O	5	VC	O
O	O	O	820	822	by	by	B-PP	IN	O	6	VMOD	O
O	O	O	823	825	an	an	B-NP	DT	O	10	NMOD	O
O	O	O	826	833	initial	initial	I-NP	JJ	O	10	NMOD	O
O	O	O	834	842	decrease	decrease	I-NP	NN	O	13	NMOD	O
O	O	O	843	846	and	and	O	CC	O	13	NMOD	O
O	O	O	847	857	subsequent	subsequent	B-NP	JJ	O	13	NMOD	O
O	O	O	858	866	increase	increase	I-NP	NN	O	7	PMOD	O
O	O	O	867	869	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	870	873	the	the	B-NP	DT	O	18	NMOD	O
O	O	O	874	885	cytoplasmic	cytoplasmic	I-NP	JJ	O	18	NMOD	O
T12	B-Protein	B-Protein	886	898	IkappaBalpha	IkappaBalpha	I-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	899	905	levels	level	I-NP	NNS	O	14	PMOD	O
O	O	O	905	906	,	,	O	,	O	5	P	O
O	O	O	907	909	as	as	B-SBAR	IN	O	5	VMOD	O
O	O	O	910	918	detected	detect	B-VP	VBN	O	20	SBAR	O
O	O	O	919	921	by	by	B-PP	IN	O	21	VMOD	O
O	O	O	922	929	Western	Western	B-NP	JJ	O	24	NMOD	O
O	O	O	930	938	blotting	blotting	I-NP	NN	O	22	PMOD	O
O	O	O	939	944	using	use	B-VP	VBG	O	24	NMOD	O
O	O	O	945	947	an	an	B-NP	DT	O	30	NMOD	O
O	O	O	948	952	anti	anti	I-NP	AFX	O	30	NMOD	O
O	O	O	952	953	-	-	I-NP	HYPH	B-protein	30	NMOD	B-protein
T13	B-Protein	B-Protein	953	965	IkappaBalpha	IkappaBalpha	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	966	974	antibody	antibody	I-NP	NN	I-protein	25	OBJ	I-protein
O	O	O	974	975	.	.	O	.	O	5	P	O

T25	B-Entity	B-Entity	976	985	Pertussis	Pertussis	B-NP	NN	O	3	NMOD	O
T25	I-Entity	I-Entity	986	991	toxin	toxin	I-NP	NN	O	3	NMOD	O
O	O	O	992	1001	treatment	treatment	I-NP	NN	O	5	SUB	O
O	O	O	1002	1010	markedly	markedly	B-ADVP	RB	O	5	VMOD	O
O	O	O	1011	1020	decreased	decrease	B-VP	VBD	O	0	ROOT	O
T26	B-Entity	B-Entity	1021	1027	kappaB	kappaB	B-NP	NN	B-protein	8	NMOD	B-protein
O	O	O	1028	1035	binding	binding	I-NP	NN	O	8	NMOD	O
O	O	O	1036	1046	activities	activity	I-NP	NNS	O	5	OBJ	O
O	O	O	1047	1054	induced	induce	B-VP	VBN	O	8	NMOD	O
O	O	O	1055	1057	by	by	B-PP	IN	O	9	VMOD	O
O	O	O	1058	1062	both	both	O	CC	O	14	NMOD	O
T14	B-Protein	B-Protein	1063	1066	C5a	C5a	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	1067	1070	and	and	O	CC	O	14	NMOD	O
T15	B-Protein	B-Protein	1071	1074	C3a	C3a	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	O	1074	1075	,	,	O	,	O	5	P	O
O	O	O	1076	1083	whereas	whereas	O	IN	O	5	VMOD	O
O	O	O	1084	1091	cholera	cholera	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	O	1092	1097	toxin	toxin	I-NP	NN	I-protein	19	SUB	I-protein
O	O	O	1098	1107	displayed	display	B-VP	VBD	O	16	SBAR	O
O	O	O	1108	1110	no	no	B-NP	DT	O	22	NMOD	O
O	O	O	1111	1121	inhibitory	inhibitory	I-NP	JJ	O	22	NMOD	O
O	O	O	1122	1128	effect	effect	I-NP	NN	O	19	OBJ	O
O	O	O	1128	1129	.	.	O	.	O	5	P	O

O	O	O	1130	1137	Neither	Neither	B-NP	DT	O	6	SUB	O
O	O	O	1138	1140	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1141	1144	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1145	1148	two	two	I-NP	CD	O	5	NMOD	O
O	O	O	1149	1155	toxins	toxin	I-NP	NNS	O	2	PMOD	O
O	O	O	1156	1164	affected	affect	B-VP	VBD	O	0	ROOT	O
O	O	O	1165	1171	kappaB	kappaB	B-NP	NN	B-protein	9	NMOD	B-protein
O	O	O	1172	1179	binding	binding	I-NP	NN	O	9	NMOD	O
O	O	O	1180	1188	activity	activity	I-NP	NN	O	6	OBJ	O
O	O	O	1189	1196	induced	induce	B-VP	VBN	O	9	NMOD	O
O	O	O	1197	1199	by	by	B-PP	IN	O	10	VMOD	O
T16	B-Protein	B-Protein	1200	1208	TNFalpha	TNFalpha	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	O	1209	1211	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	1212	1215	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1216	1220	same	same	I-NP	JJ	O	16	NMOD	O
O	O	O	1221	1226	cells	cell	I-NP	NNS	O	13	PMOD	O
O	O	O	1226	1227	.	.	O	.	O	6	P	O

O	O	O	1228	1233	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1234	1241	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1242	1247	imply	imply	B-VP	VBP	O	0	ROOT	O
O	O	O	1248	1249	a	a	B-NP	DT	O	6	NMOD	O
O	O	O	1250	1259	potential	potential	I-NP	JJ	O	6	NMOD	O
O	O	O	1260	1264	role	role	I-NP	NN	O	3	OBJ	O
O	O	O	1265	1267	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	1268	1271	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1272	1286	anaphylatoxins	anaphylatoxin	I-NP	NNS	B-protein	12	NMOD	B-protein
T17	B-Protein	B-Protein	1287	1290	C5a	C5a	I-NP	NN	B-protein	12	NMOD	B-protein
O	O	O	1291	1294	and	and	I-NP	CC	O	12	NMOD	O
T18	B-Protein	B-Protein	1295	1298	C3a	C3a	I-NP	NN	B-protein	7	PMOD	B-protein
O	O	O	1299	1301	in	in	B-PP	IN	O	3	VMOD	O
O	O	O	1302	1312	regulating	regulate	B-VP	VBG	O	13	PMOD	O
O	O	O	1313	1323	leukocytes	leukocyte	B-NP	NNS	O	17	NMOD	O
O	O	O	1324	1328	gene	gene	I-NP	NN	O	17	NMOD	O
O	O	O	1329	1339	expression	expression	I-NP	NN	O	14	OBJ	O
O	O	O	1340	1347	through	through	B-PP	IN	O	14	VMOD	O
O	O	O	1348	1349	G	G	B-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1350	1357	protein	protein	I-NP	NN	I-protein	18	PMOD	I-protein
O	O	O	1357	1358	-	-	B-NP	HYPH	O	25	NMOD	O
O	O	O	1358	1365	coupled	couple	I-NP	VBN	O	25	NMOD	O
O	O	O	1366	1379	transcription	transcription	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	1380	1386	factor	factor	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	O	1387	1397	activation	activation	I-NP	NN	O	13	PMOD	O
O	O	O	1397	1398	.	.	O	.	O	3	P	O
